Sjanie Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sjanie Huang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Dirk J. Lefeber
Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands
3 shared publications Afitz Da Silva
Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Center, University of Montréal , 3175 chemin de la Côte-Sainte-Catherine, Montréal QC H3T 1C5
1 shared publication- Afitz Da Silva
IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France
1 shared publication - Alejandro Garanto
Department of Pediatrics, Radboud University Medical Center, Amalia Children’s Hospital, Nijmegen, The Netherlands
1 shared publication Aleksander Hinek
Hospital for Sick Children Research Institute, Toronto, ON, Canada
1 shared publicationAlexey V Pshezhetsky
Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Center, University of Montréal , 3175 chemin de la Côte-Sainte-Catherine, Montréal QC H3T 1C5
1 shared publication
Latest Publications
- Open Access
- 18 May 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36 (7)
Cellular homeostasis of N -acetylneuraminic acid and non-canonical sialic acids is mediated by human N -acetylneuraminate lyase
Sialic acids are important for cellular communication, with N-acetylneuraminic acid (Neu5Ac) being the canonical form of sialic acid in humans. Presence of non-canonical sialic acids, derived from dietary intake or as metabolic side product, has been linked to immune disorders and cancer. As homeostasis of different sialic acids remains poorly understood in humans, we studied the role of N-acetylneuraminate lyase (NPL) in their catabolism. In vitro expression of NPL in different biological systems revealed broad substrate specificity towards sialic acids and related 2-keto-3-deoxy metabolites. In agreement with the broad substrate specificity, NPL-deficient red blood cells accumulated Neu5Ac and 3-deoxy-d-glycero-d-galacto-nonulosonic acid (KDN). Interestingly, endogenous levels of non-canonical sialic acids, including N-glycolylneuraminic acid (Neu5Gc) and KDN, were depleted in HEK293T cells upon NPL overexpression, while Neu5Ac and CMP-Neu5Ac levels remained stable. This was further confirmed by supplementation with different sialic acids. Detailed analysis of sugar phosphate intermediates of the hexosamine and sialic acid biosynthesis pathways showed strongly elevated ManNAc-6P (N-acetyl-d-mannosamine 6-phosphate) and Neu5Ac-9P, indicating efficient recycling of ManNAc to increase de novo Neu5Ac biosynthesis. However, this recycling was not efficient for Neu5Gc and KDN. While GlcNAc-6P (N-acetyl-d-glucosamine 6-phosphate) levels were slightly elevated, no evidence was found for further metabolism towards GlcN-6P (glucosamine 6-phosphate) and energy production via glycolysis as shown for bacterial neuraminate lyases. In conclusion, human NPL catabolizes a broad range of sialic acids. However, depending on the cellular context, NPL contributes to a net cellular reduction in non-canonical sialic acids, such as KDN, due to a lack of efficient recycling.
- 18 May 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36 (7)
Open AccessCellular homeostasis of N -acetylneuraminic acid and non-canonical sialic acids is mediated by human N -acetylneuraminate lyase
Sialic acids are important for cellular communication, with N-acetylneuraminic acid (Neu5Ac) being the canonical form of sialic acid in humans. Presence of non-canonical sialic acids, derived from dietary intake or as metabolic side product, has been linked to immune disorders and cancer. As homeostasis of different sialic acids remains poorly understood in humans, we studied the role of N-acetylneuraminate lyase (NPL) in their catabolism. In vitro expression of NPL in different biological systems revealed broad substrate specificity towards sialic acids and related 2-keto-3-deoxy metabolites. In agreement with the broad substrate specificity, NPL-deficient red blood cells accumulated Neu5Ac and 3-deoxy-d-glycero-d-galacto-nonulosonic acid (KDN). Interestingly, endogenous levels of non-canonical sialic acids, including N-glycolylneuraminic acid (Neu5Gc) and KDN, were depleted in HEK293T cells upon NPL overexpression, while Neu5Ac and CMP-Neu5Ac levels remained stable. This was further confirmed by supplementation with different sialic acids. Detailed analysis of sugar phosphate intermediates of the hexosamine and sialic acid biosynthesis pathways showed strongly elevated ManNAc-6P (N-acetyl-d-mannosamine 6-phosphate) and Neu5Ac-9P, indicating efficient recycling of ManNAc to increase de novo Neu5Ac biosynthesis. However, this recycling was not efficient for Neu5Gc and KDN. While GlcNAc-6P (N-acetyl-d-glucosamine 6-phosphate) levels were slightly elevated, no evidence was found for further metabolism towards GlcN-6P (glucosamine 6-phosphate) and energy production via glycolysis as shown for bacterial neuraminate lyases. In conclusion, human NPL catabolizes a broad range of sialic acids. However, depending on the cellular context, NPL contributes to a net cellular reduction in non-canonical sialic acids, such as KDN, due to a lack of efficient recycling.
- Open Access
- 6 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111262
Biosynthetic and genetic pathways related to sialic acid metabolism
- 6 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111262
Open AccessBiosynthetic and genetic pathways related to sialic acid metabolism
- Open Access
- 30 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (26) , eade6308
N -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function
Deleterious variants in N- acetylneuraminate pyruvate lyase (NPL) cause skeletal myopathy and cardiac edema in humans and zebrafish, but its physiological role remains unknown. We report generation of mouse models of the disease: Npl R63C , carrying the human p.Arg63Cys variant, and Npl del116 with a 116-bp exonic deletion. In both strains, NPL deficiency causes drastic increase in free sialic acid levels, reduction of skeletal muscle force and endurance, slower healing and smaller size of newly formed myofibers after cardiotoxin-induced muscle injury, increased glycolysis, partially impaired mitochondrial function, and aberrant sialylation of dystroglycan and mitochondrial LRP130 protein. NPL-catalyzed degradation of sialic acid in the muscle increases after fasting and injury and in human patient and mouse models with genetic muscle dystrophy, demonstrating that NPL is essential for muscle function and regeneration and serves as a general marker of muscle damage. Oral administration of N- acetylmannosamine rescues skeletal myopathy, as well as mitochondrial and structural abnormalities in Npl R63C mice, suggesting a potential treatment for human patients.
- 30 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (26) , eade6308
Open AccessN -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function
Deleterious variants in N- acetylneuraminate pyruvate lyase (NPL) cause skeletal myopathy and cardiac edema in humans and zebrafish, but its physiological role remains unknown. We report generation of mouse models of the disease: Npl R63C , carrying the human p.Arg63Cys variant, and Npl del116 with a 116-bp exonic deletion. In both strains, NPL deficiency causes drastic increase in free sialic acid levels, reduction of skeletal muscle force and endurance, slower healing and smaller size of newly formed myofibers after cardiotoxin-induced muscle injury, increased glycolysis, partially impaired mitochondrial function, and aberrant sialylation of dystroglycan and mitochondrial LRP130 protein. NPL-catalyzed degradation of sialic acid in the muscle increases after fasting and injury and in human patient and mouse models with genetic muscle dystrophy, demonstrating that NPL is essential for muscle function and regeneration and serves as a general marker of muscle damage. Oral administration of N- acetylmannosamine rescues skeletal myopathy, as well as mitochondrial and structural abnormalities in Npl R63C mice, suggesting a potential treatment for human patients.